These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19040283)

  • 1. Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays.
    El Sharkawi FZ; Chudy M; Hanschmann KM; Kress J; Nübling CM
    J Med Virol; 2008 Dec; 80(12):2086-91. PubMed ID: 19040283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
    Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
    Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
    Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].
    Takenokuchi M; Yasuda C; Nakamachi Y; Mukai M; Yoon S; Kondoh S; Kumagai S
    Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
    Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
    J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ; Majewski DW; Yung B; Mitchell PS; Yao JD
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Heath AB;
    Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
    Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D;
    J Virol Methods; 2012 Apr; 181(1):131-3. PubMed ID: 22285372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
    Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
    Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
    Hofmann WP; Dries V; Herrmann E; Gärtner B; Zeuzem S; Sarrazin C
    J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
    Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
    Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4.
    Zekri AR; El-Din HM; Bahnassy AA; El-Shehabi AM; El-Leethy H; Omar A; Khaled HM
    J Med Virol; 2005 Mar; 75(3):412-20. PubMed ID: 15648068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.